Valois targets compliance with equadel add-ons
Valois Pharma has informed in-PharmaTechnologist that it is developing a range of add-ons for its equadel nasal drug delivery device, which the company believes will help improve patient compliance.
Valois Pharma has informed in-PharmaTechnologist that it is developing a range of add-ons for its equadel nasal drug delivery device, which the company believes will help improve patient compliance.
A new report suggests the large numbers of fake drugs produced in China could drive CMO customers away and see Central and Eastern Europe (CEE) emerge as a contract manufacturing hotbed.
Preterm infants are routinely exposed to pharmaceutical excipients at levels which could potentially be toxic, according to researchers at Leicester Royal Infirmary in the UK.
UK-headquartered Premier Research Group has signed a deal to buy the assets of fellow contract research organisation (CRO) Pivotal Research Centers, a specialist in Phase I to IIa trials, for $4.75m.
A social networking tool specifically designed for patients involved in clinical trials has been set up by Acurian, a company specialising in patient recruitment services.